IL6 and endometrial cancer: Interestingly, the PI3K/AKT/mTOR pathway mediates signaling from leptin and IL-6 [62], which, in our study, have been found to be significantly elevated in type I endometrial cancer patients and positively correlated with tumor prognostic factors.